Stockholders’ Equity |
9 Months Ended |
|---|---|
Mar. 31, 2025 | |
| Equity [Abstract] | |
| Stockholders’ Equity |
Note 7. Stockholders’ Equity
On November 20, 2023, the Company filed a certificate of amendment with the Secretary of State of the State of Delaware to increase the authorized number of shares of its common stock from to shares. As amended, the Company’s authorized capital stock consists of shares of common stock, par value $ per share, and shares of preferred stock, par value $ per share.
On September 28, 2022, the Company completed a private placement financing of units (collectively, the “Units”), with each Unit consisting of (i) share of its common stock and (ii) a warrant to purchase one share of its common stock, for aggregate gross proceeds of approximately $6.6 million (or $ per Unit). The Company received approximately $6.3 million in net proceeds after deducting financing fees of approximately $0.3 million. Each warrant has an exercise price of $4.215 per share, which is subject to customary adjustments in the event of any combination or split of the Company’s common stock. The warrants expire on September 28, 2027.
On November 13, 2023, the Company issued shares of common stock in conjunction with a Loan and Security Agreement – see Note 10.
On December 22, 2024, the Company entered into a securities purchase agreement with 22NW Fund, LP (“22NW Fund”), a greater than 5% stockholder of the Company that is controlled by Aron English, a director of the Company, as well as other institutional accredited investors (the “Investors”), pursuant to which, on December 23, 2024, the Company issued and sold to the Investors, in a private placement priced at-the-market (the “Private Placement”) consistent with the rules of the Nasdaq Stock Market LLC (“Nasdaq”), an aggregate of shares (the “Shares”) of common stock. The purchase price of each Share was $, equal to the Nasdaq Minimum Price, as defined in Nasdaq Listing Rule 5635(d). The Company received aggregate gross proceeds from the Private Placement of approximately $15.0 million, before deducting offering expenses payable by the Company of approximately $0.1 million. In connection with the above transaction, the Company was required to file a registration statement on Form S-3 within sixty days of the closing of the transaction. Therefore, there were certain offering costs (primarily legal fees) associated with the equity transaction that were incurred during the three months ended March 31, 2025, related to this transaction which closed on December 22, 2024. These offering costs are presented separately in the statement of changes in stockholders’ equity for the three months ended March 31, 2025.
|